Literature DB >> 2147739

Quantitative evidence of peripheral conversion of angiotensin within the human leg: effects of local angiotensin-I administration and angiotensin-converting enzyme inhibition on regional blood flow and angiotensin-II balance across the leg.

S Gasic1, G Heinz, C Kleinbloesem.   

Abstract

The renin-angiotensin system relevantly contributes to the maintenance of systemic vascular tone and there is experimental evidence that large amounts of angiotensin-converting enzyme (ACE) are present in peripheral vascular tissues, including resistance vessels. To determine and quantify peripheral vascular conversion of angiotensin-I (ANG-I) to angiotensin-II (ANG-II) across the human leg, the response of regional blood flow to local regional intra-arterial infusion of ANG-I and change in associated ANG-II balance were evaluated during ANG-I infusion and following additional ACE inhibition. Ten sodium-loaded healthy men were enrolled in the study. Following cannulation of both femoral arteries and the right femoral vein, leg blood flow was determined (indocyanine-green dye-dilution method) at baseline conditions and during constant intra-arterial infusion of haemodynamically ineffective doses of ANG-I as well as following concomitant intra-arterial administration of low doses of the non-sulfhydril ACE inhibitor cilazapril. From the transfemoral arterio-venous differences in ANG-II plasma concentrations and the corresponding regional blood (plasma) flow, the ANG-II balance across the leg was calculated. Systemic blood pressure did not change throughout the trial, indicating that no major systemic effects were present during ANG-I infusion or concomitant ACE inhibition. Moreover, arterial ANG-II plasma concentrations were not significantly changed by ANG-I infusion. Leg blood flow decreased to below baseline values following ANG-I infusion, increasing again then in a dose-dependent manner during concomitant cilazapril administration. The calculated baseline ANG-II balance across the leg revealed a net extraction in 6 out of 10 subjects and a net ANG-II formation in 4.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2147739     DOI: 10.1007/bf00169461

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  17 in total

1.  Metabolism of dipeptides and their constituent amino acids by liver, gut, kidney, and muscle.

Authors:  H Lochs; P E Williams; E L Morse; N N Abumrad; S A Adibi
Journal:  Am J Physiol       Date:  1988-05

2.  Mechanism of angiotensin I converting enzyme inhibition by SQ20,881 (less than Glu-Trp-Pro-Arg-Pro-Gln-Ile-Pro-Pro) in vivo. Further evidence for extrapulmonary conversion.

Authors:  S Oparil; T Koerner; J K O'Donoghue
Journal:  Hypertension       Date:  1979 Jan-Feb       Impact factor: 10.190

Review 3.  Arterial wall or plasma renin in hypertension?

Authors:  J D Swales
Journal:  Clin Sci (Lond)       Date:  1979-04       Impact factor: 6.124

Review 4.  The site of angiotensin production.

Authors:  D J Campbell
Journal:  J Hypertens       Date:  1985-06       Impact factor: 4.844

5.  Effect of renin-angiotensin system on limb circulation in normal subjects.

Authors:  M A Creager; D P Faxon; S M Rockwell; J C Melby; H Gavras; J D Coffman
Journal:  Am J Physiol       Date:  1984-02

6.  Angiotensin I, II, and III in sheep. A model of angiotensin production and metabolism.

Authors:  D T Fei; B A Scoggins; G W Tregear; J P Coghlan
Journal:  Hypertension       Date:  1981 Nov-Dec       Impact factor: 10.190

7.  Biological properties of the angiotensin-converting enzyme inhibitor cilazapril.

Authors:  I L Natoff; J S Nixon; R J Francis; L R Klevans; M Brewster; J Budd; A T Patel; J Wenger; E Worth
Journal:  J Cardiovasc Pharmacol       Date:  1985 May-Jun       Impact factor: 3.105

8.  Regulation of tissue renin and angiotensin gene expressions.

Authors:  V J Dzau; J R Ingelfinger; R E Pratt
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

9.  Local actions of angiotensin II: quantitative in vitro autoradiographic localization of angiotensin II receptor binding and angiotensin converting enzyme in target tissues.

Authors:  S Y Chai; A M Allen; W R Adam; F A Mendelsohn
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

10.  Vascular angiotensin converting enzyme in the development of renal hypertension.

Authors:  M Miyazaki; T Okamura; H Okunishi; N Toda
Journal:  J Cardiovasc Pharmacol       Date:  1986       Impact factor: 3.105

View more
  1 in total

1.  Angiotensin II increases glucose utilization during acute hyperinsulinemia via a hemodynamic mechanism.

Authors:  T A Buchanan; H Thawani; W Kades; J G Modrall; F A Weaver; C Laurel; R Poppiti; A Xiang; W Hsueh
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.